Could a cell infusion free organ transplant patients from lifelong drugs?
NCT ID NCT06997471
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests whether giving a special mix of blood cells after an organ transplant can help the body accept the new organ without needing lifelong anti-rejection drugs. About 10 children and adults receiving kidney, lung, or intestinal transplants will get the cell infusion after a short preparation. The main goal is to see if the approach is safe and can reduce rejection and infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID ORGAN TRANSPLANT COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
La Paz University Hospital
RECRUITINGMadrid, Madrid, 28046, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Should you get your COVID and flu shots together? new study aims to find out for immunocompromised patients
- New cell therapy targets Epstein-Barr virus in immune-compromised patients
- Transplant patients get new hope: sirolimus cream may stop facial cancers
- Exercise after kidney transplant boosts strength and health
- Donor immune cells take on Virus-Linked cancer after transplant